Trial intelligence / Profile preview

Intravenous ivabradine for heart rate control during multislice CT coronary angiography

ISRCTN67252793Phase 4Completed

Sponsor
Servier
Start
Oct 2008
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of ivabradine in coronary arteriosclerosis (3 arms), sponsored by Servier. Primary endpoint: Primary efficacy endpoint. Started Oct 2008; status: completed.

02

Drugs

ivabradine
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ISRCTN67252793.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN67252793.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call